-
Fingolimod (FTY720) in T-Cell Engineering
2026-09-10
Fingolimod (FTY720) gives researchers a pharmacological way to test how S1P signaling, lymphocyte trafficking, and neuroprotective pathways shape immune-cell engineering studies. Paired carefully with the magnetic bispecific nano-antibody strategy from the reference study, it can separate systemic cell-distribution effects from local tumor-targeting effects without implying an unvalidated therapeutic combination.
-
Salinomycin Workflows for HCC Drug-Response Assays
2026-09-09
Build more informative hepatocellular carcinoma assays with Salinomycin by separating growth arrest from true cell killing. This workflow combines viability, apoptosis, calcium, transporter, and Wnt/β-catenin readouts to improve mechanistic interpretation and troubleshooting.
-
Nile Red for Lipid Droplet Imaging
2026-09-09
Nile Red converts intracellular lipid storage into a practical fluorescence readout, with red and green channels that help distinguish membrane-associated signal from lipid-droplet enrichment. This workflow connects lipid droplet imaging with oleic acid stress and autophagy experiments while emphasizing assay controls, channel selection, and troubleshooting.
-
Sex Differences in Angiotensin II Hypertension
2026-09-08
Xue, Pamidimukkala, and Hay used telemetry in conscious, freely moving mice to show that chronic angiotensin II produces a substantially larger hypertensive response in males than in females. Gonadectomy, baroreflex testing, and ganglionic blockade further linked this divergence to sex hormone-dependent and autonomic mechanisms, providing a rigorous framework for sex-aware cardiovascular research.
-
LDH Cytotoxicity Assay Kit for Nanomaterial Safety
2026-09-08
Use the LDH Cytotoxicity Assay Kit to quantify membrane damage during nanomaterial screening, magnetic hyperthermia studies, and broader cell cytotoxicity measurement. Its non-radioactive workflow pairs well with controls that distinguish intrinsic material toxicity from heat- or treatment-induced injury.
-
n-Dodecyl-β-D-maltoside for Integrin Cryo-EM
2026-09-07
Discover how n-Dodecyl-β-D-maltoside and DDM condition membrane-protein samples for cryo-EM without treating solubilization as the only endpoint. This article connects detergent chemistry with conformational-ensemble analysis of full-length αvβ3 integrin.
-
Clozapine Workflows for Schizophrenia Research
2026-09-05
Build translational Clozapine experiments around receptor pharmacology, ERK1/2 signaling activation, and prefrontal-circuit models. This workflow also shows how to compare chemical perturbation with selective magnetic stimulation while controlling solubility, timing, and hepatotoxicity confounders.
-
Disodium Bicinchoninate in Oxidative-Stress Assays
2026-09-05
Disodium bicinchoninate brings a water-first design to chelation and protein-normalization workflows, especially when DMSO or ethanol stocks are unsuitable. This guide connects its practical handling to inflammation and oxidative-stress experiments inspired by a biomimetic nanoparticle study, while separating validated product facts from assay-development recommendations.
-
Thiothixene for Reproducible Macrophage Assays
2026-09-04
Learn how Thiothixene (SKU C8719) can support mechanism-informed macrophage efferocytosis, viability, and cytotoxicity workflows. This scenario-based guide covers concentration selection, assay controls, interpretation, handling, and practical vendor evaluation.
-
BRCAness and Olaparib Response in Mesothelioma
2026-09-04
Borchert et al. integrate homologous recombination repair gene-expression profiling with drug-response experiments to identify malignant pleural mesothelioma models that may be vulnerable to olaparib. Their findings connect BAP1-associated BRCAness with increased apoptosis and senescence during PARP inhibition, while also highlighting candidate prognostic markers and the need for biomarker-guided validation.
-
Cdc42–β-Catenin Signaling in Kidney Fibrosis
2026-09-03
The 2024 Advanced Science study identifies daphnepedunin A, a natural diterpenoid from Wikstroemia chamaedaphne, as an anti-fibrotic compound that directly targets Cdc42. Its proposed mechanism links reduced Cdc42 activity to PKCζ/GSK-3β regulation, β-catenin degradation, and reduced fibroblast activation in cellular and unilateral ureteral obstruction models.
-
Stiripentol LDH Inhibitor Research Workflows
2026-09-03
Stiripentol is a research-grade LDH inhibitor that connects astrocyte-neuron lactate shuttle modulation with metabolic and epigenetic assay design. This workflow guide shows how to evaluate lactate flux, histone lactylation, immune-cell function, and seizure-relevant phenotypes while controlling solubility and vehicle-related artifacts.
-
(Z)-4-Hydroxytamoxifen ER Workflow Guide
2026-09-02
Build more interpretable estrogen receptor experiments with (Z)-4-Hydroxytamoxifen, from solvent handling and dose design to orthogonal pathway validation. This guide also shows how delivery, retention, and genetic-control principles from a cartilage nanoparticle study can sharpen breast cancer assay logic without overstating cross-domain evidence.
-
DOT1L Reprograms Immunity in Multiple Myeloma
2026-09-02
The 2025 Cancer Letters study shows that DOT1L inhibition activates STING-linked innate immune signaling and disrupts oncogenic transcriptional programs in multiple myeloma. Its combination with lenalidomide strengthens interferon-regulated gene expression and suppresses IRF4–MYC signaling, providing a mechanistic rationale for epigenetic–immunomodulatory drug combinations.
-
n-Dodecyl-β-D-maltoside (DDM) Guide
2026-09-01
n-Dodecyl-β-D-maltoside (DDM) is a non-ionic maltoside detergent for membrane protein solubilization and stabilization. Its practical value depends on protein identity, lipid composition, buffer conditions, and downstream assay compatibility.